Amphastar Pharmaceuticals Inc. (AMPH)
NASDAQ · Healthcare
Amphastar Pharmaceuticals Inc. Long Term Debt 2012–2025
Amphastar Pharmaceuticals Inc. annual/quarterly long term debt history from 2014 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Amphastar Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2025 were 619.7M, a 1.01% increase year-over-year.
- Amphastar Pharmaceuticals Inc. long term debt for 2025 were 619.7M, a 1.01% increase from 2024.
- Amphastar Pharmaceuticals Inc. long term debt for 2024 were 613.5M, a 1.72% increase from 2023.
- Amphastar Pharmaceuticals Inc. long term debt for 2023 were 603.2M, a 687.00% increase from 2022.
- Amphastar Pharmaceuticals Inc. long term debt for 2022 were 76.6M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Amphastar Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $620 |
| 2024 | $614 |
| 2023 | $603 |
| 2022 | $77 |
| 2021 | $78 |
| 2020 | $46 |
| 2019 | $46 |
| 2018 | $49 |
| 2017 | $46 |
| 2016 | $36 |
| 2015 | $40 |
| 2014 | $43 |
| Amphastar Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $620 |
| 2024-12-31 | $614 |
| 2023-12-31 | $603 |
| 2022-12-31 | $77 |
| 2021-12-31 | $78 |
| 2020-12-31 | $46 |
| 2019-12-31 | $46 |
| 2018-12-31 | $49 |
| 2017-12-31 | $46 |
| 2016-12-31 | $36 |
| 2015-12-31 | $40 |
| 2014-12-31 | $43 |
Amphastar Pharmaceuticals Inc. Long Term Debt — FAQ
Amphastar Pharmaceuticals Inc. (AMPH) long term debt over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMPH's long term debt history?
The chart and table above show Amphastar Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.